Literature DB >> 23761677

Novel role of ouabain as a cystogenic factor in autosomal dominant polycystic kidney disease.

Gustavo Blanco1, Darren P Wallace.   

Abstract

The classic role of the Na-K-ATPase is that of a primary active transporter that utilizes cell energy to establish and maintain transmembrane Na(+) and K(+) gradients to preserve cell osmotic stability, support cell excitability, and drive secondary active transport. Recent studies have revealed that Na-K-ATPase located within cholesterol-containing lipid rafts serves as a receptor for cardiotonic steroids, including ouabain. Traditionally, ouabain was viewed as a toxin produced only in plants, and it was used in relatively high concentrations to experimentally block the pumping action of the Na-K-ATPase. However, the new and unexpected role of the Na-K-ATPase as a signal transducer revealed a novel facet for ouabain in the regulation of a myriad of cell functions, including cell proliferation, hypertrophy, apoptosis, mobility, and metabolism. The seminal discovery that ouabain is endogenously produced in mammals and circulates in plasma has fueled the interest in this endogenous molecule as a potentially important hormone in normal physiology and disease. In this article, we review the role of the Na-K-ATPase as an ion transporter in the kidney, the experimental evidence for ouabain as a circulating hormone, the function of the Na-K-ATPase as a signal transducer that mediates ouabain's effects, and novel results for ouabain-induced Na-K-ATPase signaling in cystogenesis of autosomal dominant polycystic kidney disease.

Entities:  

Keywords:  Na-K-ATPase signalosome; cardiotonic steroids; polycystic kidney disease

Mesh:

Substances:

Year:  2013        PMID: 23761677      PMCID: PMC3761286          DOI: 10.1152/ajprenal.00248.2013

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  243 in total

1.  Identification and characterization of a ouabain-like compound from human plasma.

Authors:  J M Hamlyn; M P Blaustein; S Bova; D W DuCharme; D W Harris; F Mandel; W R Mathews; J H Ludens
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-15       Impact factor: 11.205

2.  Functional characterization of Src-interacting Na/K-ATPase using RNA interference assay.

Authors:  Man Liang; Ting Cai; Jiang Tian; Weikai Qu; Zi-Jian Xie
Journal:  J Biol Chem       Date:  2006-05-12       Impact factor: 5.157

3.  The effect of paclitaxel on the progression of polycystic kidney disease in rodents.

Authors:  J R Martinez; B D Cowley; V H Gattone; S Nagao; T Yamaguchi; S Kaneta; H Takahashi; J J Grantham
Journal:  Am J Kidney Dis       Date:  1997-03       Impact factor: 8.860

4.  Ouabain-induced cell proliferation in cultured rat astrocytes.

Authors:  Y Murata; T Matsuda; K Tamada; R Hosoi; S Asano; K Takuma; K Tanaka; A Baba
Journal:  Jpn J Pharmacol       Date:  1996-12

5.  Increased water intake decreases progression of polycystic kidney disease in the PCK rat.

Authors:  Shizuko Nagao; Kazuhiro Nishii; Makoto Katsuyama; Hiroki Kurahashi; Tohru Marunouchi; Hisahide Takahashi; Darren P Wallace
Journal:  J Am Soc Nephrol       Date:  2006-06-28       Impact factor: 10.121

6.  Pharmacokinetics of tritiated ouabain, digoxin and digitoxin in guinea-pigs.

Authors:  D Proppe
Journal:  Clin Exp Pharmacol Physiol       Date:  1975 Nov-Dec       Impact factor: 2.557

7.  The cytoplasmic C-terminal fragment of polycystin-1 regulates a Ca2+-permeable cation channel.

Authors:  D H Vandorpe; M N Chernova; L Jiang; L K Sellin; S Wilhelm; A K Stuart-Tilley; G Walz; S L Alper
Journal:  J Biol Chem       Date:  2000-10-23       Impact factor: 5.157

8.  Transmembrane domain analysis of polycystin-1, the product of the polycystic kidney disease-1 (PKD1) gene: evidence for 11 membrane-spanning domains.

Authors:  Nancy Nims; Dianne Vassmer; Robin L Maser
Journal:  Biochemistry       Date:  2003-11-11       Impact factor: 3.162

9.  Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity.

Authors:  Katharina Hopp; Christopher J Ward; Cynthia J Hommerding; Samih H Nasr; Han-Fang Tuan; Vladimir G Gainullin; Sandro Rossetti; Vicente E Torres; Peter C Harris
Journal:  J Clin Invest       Date:  2012-10-15       Impact factor: 14.808

10.  Na,K-ATPase and the role of alpha isoforms in behavior.

Authors:  Jerry B Lingrel; Michael T Williams; Charles V Vorhees; Amy E Moseley
Journal:  J Bioenerg Biomembr       Date:  2007-12       Impact factor: 2.945

View more
  15 in total

1.  Ouabain promotes partial epithelial to mesenchymal transition (EMT) changes in human autosomal dominant polycystic kidney disease (ADPKD) cells.

Authors:  Jessica Venugopal; Jeffrey McDermott; Gladis Sanchez; Madhulika Sharma; Leandro Barbosa; Gail A Reif; Darren P Wallace; Gustavo Blanco
Journal:  Exp Cell Res       Date:  2017-04-03       Impact factor: 3.905

Review 2.  Regulation of renal function and structure by the signaling Na/K-ATPase.

Authors:  Jeffrey X Xie; Xin Li; Zijian Xie
Journal:  IUBMB Life       Date:  2013-12-10       Impact factor: 3.885

3.  Ouabain Regulates CFTR-Mediated Anion Secretion and Na,K-ATPase Transport in ADPKD Cells.

Authors:  Kyle Jansson; Jessica Venugopal; Gladis Sánchez; Brenda S Magenheimer; Gail A Reif; Darren P Wallace; James P Calvet; Gustavo Blanco
Journal:  J Membr Biol       Date:  2015-08-20       Impact factor: 1.843

4.  21-Benzylidene digoxin decreases proliferation by inhibiting the EGFR/ERK signaling pathway and induces apoptosis in HeLa cells.

Authors:  Marco Túlio C Pessôa; Jéssica M M Valadares; Sayonarah C Rocha; Simone C Silva; Jeff P McDermott; Gladis Sánchez; Fernando P Varotti; Cristóforo Scavone; Rosy I M A Ribeiro; José A F P Villar; Gustavo Blanco; Leandro A Barbosa
Journal:  Steroids       Date:  2019-12-06       Impact factor: 2.668

5.  Urinary biomarkers at early ADPKD disease stage.

Authors:  Katja Petzold; Diane Poster; Fabienne Krauer; Katharina Spanaus; Gustav Andreisek; Thi Dan Linh Nguyen-Kim; Ivana Pavik; Thien Anh Ho; Andreas L Serra; Laura Rotar
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

Review 6.  Much More than a Cardiotonic Steroid: Modulation of Inflammation by Ouabain.

Authors:  Luiz H A Cavalcante-Silva; Éssia de Almeida Lima; Deyse C M Carvalho; José M de Sales-Neto; Anne K de Abreu Alves; José G F M Galvão; Juliane S de França da Silva; Sandra Rodrigues-Mascarenhas
Journal:  Front Physiol       Date:  2017-11-10       Impact factor: 4.566

Review 7.  On the Many Actions of Ouabain: Pro-Cystogenic Effects in Autosomal Dominant Polycystic Kidney Disease.

Authors:  Jessica Venugopal; Gustavo Blanco
Journal:  Molecules       Date:  2017-05-03       Impact factor: 4.411

8.  Prostaglandin E2 stimulates the epithelial sodium channel (ENaC) in cultured mouse cortical collecting duct cells in an autocrine manner.

Authors:  Morag K Mansley; Christian Niklas; Regina Nacken; Kathrin Mandery; Hartmut Glaeser; Martin F Fromm; Christoph Korbmacher; Marko Bertog
Journal:  J Gen Physiol       Date:  2020-08-03       Impact factor: 4.086

9.  A caveolin binding motif in Na/K-ATPase is required for stem cell differentiation and organogenesis in mammals and C. elegans.

Authors:  Xiaoliang Wang; Liquan Cai; Jeffrey X Xie; Xiaoyu Cui; Jue Zhang; Jiayan Wang; Yiliang Chen; Isabel Larre; Joseph I Shapiro; Sandrine V Pierre; Dianqing Wu; Guo-Zhang Zhu; Zijian Xie
Journal:  Sci Adv       Date:  2020-05-27       Impact factor: 14.136

10.  Ouabain Enhances ADPKD Cell Apoptosis via the Intrinsic Pathway.

Authors:  Jessica Venugopal; Gustavo Blanco
Journal:  Front Physiol       Date:  2016-03-24       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.